| Nom anglais | Code de recherche | Phase de R&D | Entreprise | Indication | Essai clinique |
|---|---|---|---|---|---|
| DR-01 | DR-01 | Phase 2 Clinical | Dren Bio Inc | Leukemia; Enteropathy-Associated T-Cell Lymphoma; Lymphoma, Extranodal NK-T-Cell; Lymphoma; Lymphoma, T-Cell; Bacterial Infections; Autoimmune Diseases of the Nervous System; Leukemia, Large Granular Lymphocytic | Details |